SULTRIN TRIPLE SULFA CRM DIN 00153605
Status: Cancelled Post Market
Holder: ORTHO PHARMACEUTICAL, DIVISION OF JANSSEN-ORTHO INC.
Molecule: SULFATHIAZOLE
Health Canada record
| Active ingredient(s) | SULFATHIAZOLE 3.42 %; SULFACETAMIDE 2.86 %; SULFANILYLBENZAMIDE 3.7 %; UREA 0.64 % |
|---|---|
| Dosage form | Cream |
| Route | Vaginal |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G01AE10 COMBINATIONS OF SULFONAMIDES |
| Original market date | 31-Dec-1946 |
| Current status date | 14-Apr-1999 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SULFATHIAZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00391492 | TRISULFA G LIQ | NORDEN LABORATORIES INC. | Liquid | SULFATHIAZOLE 45 MG; SULFAPYRIDINE 20 MG; SULFAMETHAZINE 45 MG | Cancelled Post Market |
International API supply for SULFATHIAZOLE
0 active FDA Drug Master Files.
Request a quote for SULTRIN TRIPLE SULFA CRM